Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study

The COVID-19 Genomics UK (COG-UK) Consortium, Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Alison Holmes, Nicholas Machin, Gee Yen Shin, Tabitha W. Mahungu, Kordo Saeed, Tranprit Saluja, Yusri Taha, Nikunj Mahida, Cassie F. Pope, Anu Chawla, Maria Teresa Cutino-Moguel, Asif Tamuri, Rachel Williams, Alistair DarbyDavid L. Robertson, Flavia Flaviani, Eleni Nastouli, Samuel Robson, Darren Smith, Kenneth Laing, Irene M. Monahan, Beatrix Kele, Sam Haldenby, Ryan George, Matthew Bashton, Adam A. Witney, Matthew Byott, Francesc Coll, Michael Chapman, Sharon J. Peacock, Joseph Hughes, Gaia Nebbia, David G. Partridge, Matthew Parker, James Richard Price, Christine Peters, Sunando Roy, Luke B. Snell, Thushan I. de Silva, Emma C. Thomson, Paul Flowers, Andrew Copas, Judith Breuer*, Clare McCann, Gregory R. Young, Andrew Nelson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds